Scientists from Imperial College London in UK are planning a
clinical study to test a stem cell treatment in upto 150
patients with multiple sclerosis across Europe. The trial, led
by Dr Paolo Muraro from Imperial College London, is reportedly
set to begin later this year. People involved in the study are
saying that it’s the first trial of its kind to test the
potential of stem cells to treat the neurological disorder. The
plan is to harvest stem cells from the bone marrow of
participants, grow them in a lab, and then implant them in
multiple sclerosis patients. Researchers are hoping that the
cells might even reverse some of the nerve damage caused by the
chronic condition, which impacts about 100,000 people in the
U.K. and 3 million patients globally, according to a BBC report.
“Stem cells have great potential to treat MS. The effect we are
looking to achieve will mean fewer relapses, stop the
progression of neurological dysfunction and even reduce
disability,” said Dr Paolo Muraro. It’s likely to be a few